GSK reports strong VMS growth amid COVID-19

4 August 2020 - Deborah Wilkes

Premium

GlaxoSmithKline (GSK) Consumer Healthcare’s sales of vitamins, minerals and supplements (VMS) “continued to grow strongly” in the second quarter of 2020, according to the company.

Click tags below for more information on topics:

GlaxoSmithKline COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: